Surlux Diagnostic Ltd.
| BSE: 507854 | Sector: Health care |
| NSE: N.A. | ISIN Code: N.A. |
| BSE 05:30 | 01 Jan | Surlux Diagnostic Ltd |
| NSE 05:30 | 01 Jan | Surlux Diagnostic Ltd |
Surlux Diagnostic Ltd. (SURLUXDIAGNO) - Competition
| COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
| Sun Pharma.Inds. | 687.55 | 164,963.87 | 12,531.93 | 3,211.14 | 32,355.78 |
| Divi's Lab. | 4,892.45 | 129,870.09 | 5,310.57 | 1,372.71 | 7,370.84 |
| Dr Reddy's Labs | 4,730.20 | 78,691.61 | 13,349.10 | 2,186.40 | 18,266.10 |
| Cipla | 890.05 | 71,795.88 | 12,659.15 | 2,318.17 | 17,704.77 |
| Gland Pharma | 3,910.90 | 64,216.98 | 2,633.24 | 772.86 | 3,653.86 |
| Cadila Health. | 577.85 | 59,154.51 | 7,790.40 | 1,476.20 | 16,841.70 |
| Apollo Hospitals | 4,029.90 | 57,941.90 | 9,794.50 | 470.30 | 8,570.00 |
| Piramal Enterp. | 2,310.05 | 55,129.34 | 1,824.70 | 39.90 | 29,983.67 |
| Aurobindo Pharma | 915.15 | 53,618.64 | 13,266.48 | 1,872.74 | 16,809.46 |
| Torrent Pharma. | 3,084.10 | 52,189.14 | 6,450.83 | 1,137.85 | 10,618.60 |
| Lupin | 1,103.35 | 50,086.57 | 11,055.93 | 1,258.62 | 19,354.36 |
| Biocon | 381.70 | 45,826.90 | 2,028.40 | 280.50 | 8,024.20 |
| Alkem Lab | 3,372.10 | 40,313.46 | 7,219.68 | 1,685.08 | 9,195.63 |
| Abbott India | 17,889.05 | 38,014.23 | 4,310.02 | 690.69 | 2,844.49 |
| Laurus Labs | 618.85 | 33,207.49 | 4,768.72 | 956.11 | 4,255.44 |
| Dr Lal Pathlabs | 3,622.30 | 30,188.25 | 1,490.56 | 280.11 | 1,320.83 |
| Ipca Labs. | 2,180.00 | 27,653.30 | 4,367.43 | 652.46 | 4,185.23 |
| Pfizer | 6,020.25 | 27,542.64 | 2,151.65 | 509.13 | 3,534.54 |
| Glaxosmi. Pharma | 1,612.95 | 27,324.99 | 3,193.74 | 357.57 | 1,798.50 |
| Max Healthcare | 274.40 | 26,505.67 | 1,156.91 | 27.88 | 2,268.34 |
Quick Links for Surlux Diagnostic:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
